Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target
hsa-miR-628-3p
-- Functional MTI --
ARSJ
Validation Method
miRNA effects on biological function
Conditions
HEK293
Disease
79642.0
Location of target site
3'UTR
Tools used in this research
TargetScan
,
miRTarCLIP
,
Piranha
Original Description (Extracted from the article)
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
...
- Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011,
Nature methods .
miRNA-target interactions (Provided by authors)
ID
Duplex structure
Position
1
miRNA 3' agcugacgGUGAGAAUGAUCu 5'
|||| |||||||
Target 5' uuucuaaaCACU-UUACUAG- 3'
16 - 34
Article
- Kishore S; Jaskiewicz L; Burger L; Hausser et al.
- Nature methods , 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [ PMID: 21572407 ]
CLIP-seq Support 1 for dataset GSM4903833
Method / RBP
HITS-CLIP / AGO
Cell line / Condition
Dermal fibroblasts / CTL_TD_21_a
Location of target site
NM_024590 | 3UTR | CAUGUGAACAGCUUGCACCUCAUUUUACCAUGCGUGAGGGAAUGGCAAAUAAGAAUGUUUGAGCACACUGCCCACAAUGAAUGUAACUAUUUUCUAAACACUUUACUAGAAGAAC
Tools used in this analysis
TargetScan, miRTarCLIP, and Piranha
Accession Series
GSE161239
CLIP-seq Viewer
Link
CLIP-seq Support 2 for dataset GSM4903836
Method / RBP
HITS-CLIP / AGO
Cell line / Condition
Dermal fibroblasts / 124_TD_21_a
Location of target site
NM_024590 | 3UTR | GCUUGCACCUCAUUUUACCAUGCGUGAGGGAAUGGCAAAUAAGAAUGUUUGAGCACACUGCCCACAAUGAAUGUAACUAUUUUCUAAACACUUUACUAGAAGAAC
Tools used in this analysis
TargetScan, miRTarCLIP, and Piranha
Accession Series
GSE161239
CLIP-seq Viewer
Link
CLIP-seq Support 3 for dataset GSM4903837
Method / RBP
HITS-CLIP / AGO
Cell line / Condition
Dermal fibroblasts / 124_TD_21_b
Location of target site
NM_024590 | 3UTR | ACCUCAUUUUACCAUGCGUGAGGGAAUGGCAAAUAAGAAUGUUUGAGCACACUGCCCACAAUGAAUGUAACUAUUUUCUAAACACUUUACUAGAAGAAC
Tools used in this analysis
TargetScan, miRTarCLIP, and Piranha
Accession Series
GSE161239
CLIP-seq Viewer
Link
CLIP-seq Support 4 for dataset GSM4903838
Method / RBP
HITS-CLIP / AGO
Cell line / Condition
Dermal fibroblasts / 124_TD_21_c
Location of target site
NM_024590 | 3UTR | CUCACAUGUGAACAGCUUGCACCUCAUUUUACCAUGCGUGAGGGAAUGGCAAAUAAGAAUGUUUGAGCACACUGCCCACAAUGAAUGUAACUAUUUUCUAAACACUUUACUAGAAGAAC
Tools used in this analysis
TargetScan, miRTarCLIP, and Piranha
Accession Series
GSE161239
CLIP-seq Viewer
Link
CLIP-seq Support 5 for dataset GSM714644
Method / RBP
PAR-CLIP / AGO2
Cell line / Condition
HEK293 / completeT1, repA
Location of target site
ENST00000315366.7 | 3UTR | AAUGAAUGUAACUAUUUUCUAAACACUUUACUAG
Tools used in this analysis
TargetScan, miRTarCLIP, and Piranha
Article / Accession Series
PMID: 21572407 / GSE28865
CLIP-seq Viewer
Link
MiRNA-Target Expression Profile
MiRNA-Target Expression Profile (TCGA)
miRNA-Drug Resistance Associations
miRNA
Drug Name
CID
NSC
FDA
Effect/Pattern
Detection Method
Level
Phenotype
Condition
hsa-mir-628
Cisplatin
5460033
NSC119875
approved
sensitive
cell line (BxPC3)
hsa-miR-628-3p
Cisplatin
5460033
NSC119875
approved
resistant
High
Tongue Squamous Cell Carcinoma
cell line (Tca8113)
hsa-miR-628-3p
Tamoxifen
2733525
NSC180973
approved
resistant
High
Breast Cancer
cell line (MCF-7, LY2)
hsa-miR-628-3p
Erlotinib
176870
NSC718781
approved
sensitive
High
Epithelial Cancer
cell line (A549, UKY-29, H460, H1975, H1650, H3255, PC-9, H358)
hsa-miR-628-3p
Siop Treatment Protocol
sensitive
High
Nephroblastoma
tissue
hsa-miR-628-3p
Sunitinib
5329102
NSC750690
approved
resistant
High
Metastatic Renal Cell Carcinoma
tissue and cell line (Caki-2)
hsa-miR-628-3p
Chemotherapy
sensitive
High
Epithelial Ovarian Cancer
tissue
hsa-miR-628-3p
Platinum-based doublet chemotherapy
resistant
Low
Lung Adenocarcinoma
tissue
hsa-miR-628-3p
Doxorubicin
31703
NSC123127
approved
sensitive
High
Gastric Cancer
cell line (SGC7901)
hsa-miR-628-3p
Tamoxifen
2733525
NSC180973
approved
resistant
High
Breast Cancer
cell line (TAMR8)
hsa-miR-628-3p
Aromatase Inhibitor
sensitive
Low
Breast Cancer
cell line (MCF-7)
hsa-miR-628-3p
Dabrafenib
44462760
NSC764134
approved
resistant
High
Melanoma
cell line (A375, IGR37, 501Mel)
hsa-miR-628-3p
Vemurafenib
42611257
NSC761431
approved
resistant
High
Melanoma
cell line (A375, IGR37, 501Mel)
hsa-miR-628-3p
Ceritinib
57379345
NSC776422
approved
sensitive
High
Non-Small Cell Lung Cancer
cell line (H3122, H2228)
hsa-miR-628-3p
Platinum
23939
sensitive
High
High-Grade Serous Ovarian Cancer
tissue
hsa-miR-628-3p
Cisplatin
5460033
NSC119875
approved
sensitive
High
Bladder Cancer
cell line (CDDP-R-BOY, CDDP-R-T24)
hsa-miR-628-3p
Gefitinib
123631
NSC715055
approved
resistant
cell line (HCC827)
hsa-miR-628-3p
Gefitinib
123631
NSC715055
approved
sensitive
cell line (HCC827)
hsa-miR-628-3p
Fluorouracil
3385
NSC19893
approved
resistant
cell line (KM12C) (72 h)
hsa-miR-628-3p
Sunitinib
5329102
NSC750690
approved
resistant
tissue (CardB)
hsa-miR-628-3p
Tamoxifen
2733525
NSC180973
approved
resistant
cell line (TamR8)
hsa-miR-628-3p
Oxaliplatin
6857599
NSC266046
approved
sensitive
cell line (IGROV-1)
hsa-miR-628-3p
Cisplatin
5460033
NSC119875
approved
sensitive
cell line (A549)
hsa-miR-628-3p
Gemcitabine
60750
NSC613327
approved
sensitive
cell line (PANC-1) (1500 ng/ml)
hsa-miR-628-3p
Docetaxel+Cisplatin+5-Fluorouracil
sensitive
tissue (hypopharyngeal squamous cell carcinoma)